Nebula Research & Development LLC Amneal Pharmaceuticals, Inc. Transaction History
Nebula Research & Development LLC
- $464 Billion
- Q1 2024
A detailed history of Nebula Research & Development LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 96,783 shares of AMRX stock, worth $614,572. This represents 0.13% of its overall portfolio holdings.
Number of Shares
96,783
Previous 41,194
134.94%
Holding current value
$614,572
Previous $250 Million
134.56%
% of portfolio
0.13%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
178Shares Held
107MCall Options Held
330KPut Options Held
81.9K-
Vanguard Group Inc Valley Forge, PA13.7MShares$87.2 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$78.3 Million1.57% of portfolio
-
Fosun International LTD12.3MShares$78.2 Million54.23% of portfolio
-
Rubric Capital Management LP New York, NY9.54MShares$60.6 Million1.97% of portfolio
-
Black Rock Inc. New York, NY9.16MShares$58.2 Million0.0% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $961M
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...